K. Peerlinck

703 total citations
17 papers, 524 citations indexed

About

K. Peerlinck is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, K. Peerlinck has authored 17 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 6 papers in Genetics and 2 papers in Surgery. Recurrent topics in K. Peerlinck's work include Hemophilia Treatment and Research (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (6 papers). K. Peerlinck is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (6 papers). K. Peerlinck collaborates with scholars based in Belgium, United States and Sweden. K. Peerlinck's co-authors include Marc Jacquemin, Kathleen Freson, Marc Hoylaerts, Chris Van Geet, David Cassiman, Frederik Nevens, Peter Witters, Chris Verslype, Cédric Hermans and Frits R. Rosendaal and has published in prestigious journals such as Blood, Annals of Oncology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

K. Peerlinck

17 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Peerlinck Belgium 11 291 91 85 84 84 17 524
Markus Pihusch Germany 14 417 1.4× 74 0.8× 76 0.9× 74 0.9× 104 1.2× 20 674
Omri Cohen Israel 10 115 0.4× 62 0.7× 69 0.8× 34 0.4× 60 0.7× 39 345
Rachel S. Bercovitz United States 13 300 1.0× 13 0.1× 82 1.0× 95 1.1× 83 1.0× 35 671
F García‐Bragado Spain 8 233 0.8× 11 0.1× 58 0.7× 155 1.8× 106 1.3× 29 474
Francesca Sartorello Italy 17 600 2.1× 51 0.6× 193 2.3× 83 1.0× 58 0.7× 27 856
Joseph E. Palascak United States 8 315 1.1× 36 0.4× 67 0.8× 104 1.2× 54 0.6× 13 538
Francesca Marangoni Italy 9 387 1.3× 27 0.3× 41 0.5× 86 1.0× 64 0.8× 18 577
Irwin Walker Canada 10 117 0.4× 10 0.1× 96 1.1× 32 0.4× 31 0.4× 15 309
Robert G. Lerner United States 10 235 0.8× 25 0.3× 297 3.5× 36 0.4× 39 0.5× 22 818
Marta Magaz Spain 13 28 0.1× 231 2.5× 139 1.6× 34 0.4× 241 2.9× 30 450

Countries citing papers authored by K. Peerlinck

Since Specialization
Citations

This map shows the geographic impact of K. Peerlinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Peerlinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Peerlinck more than expected).

Fields of papers citing papers by K. Peerlinck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Peerlinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Peerlinck. The network helps show where K. Peerlinck may publish in the future.

Co-authorship network of co-authors of K. Peerlinck

This figure shows the co-authorship network connecting the top 25 collaborators of K. Peerlinck. A scholar is included among the top collaborators of K. Peerlinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Peerlinck. K. Peerlinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jacquemin, Marc, Jaan Toelen, Luc Feyen, et al.. (2018). The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays. International Journal of Laboratory Hematology. 40(4). 442–447. 30 indexed citations
2.
Deschamps, Kevin, Filip Staes, Mariëlle Eerdekens, et al.. (2018). Postural control during a transition task in haemophilic children, adolescents and young adults with haemophilic ankle arthropathy. Haemophilia. 24(4). 667–674. 10 indexed citations
3.
Lobet, Sébastien, Olivier Cartiaux, K. Peerlinck, et al.. (2018). Assessment of passive musculoarticular ankle stiffness in children, adolescents and young adults with haemophilic ankle arthropathy. Haemophilia. 24(3). e103–e112. 7 indexed citations
4.
Jacquemin, Marc, I. Vanlinthout, Jaan Toelen, et al.. (2017). The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG‐Arg301 to be distinguished from hypofibrinogenemia. International Journal of Laboratory Hematology. 39(3). 301–307. 10 indexed citations
5.
Goossens, Godelieve, Jérôme Massiani, Willy Peetermans, et al.. (2013). Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology. 24(7). 1892–1899. 73 indexed citations
6.
Tuinenburg, A., Sara Biere‐Rafi, Matthew Peters, et al.. (2013). Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters. Haemophilia. 19(5). 744–752. 18 indexed citations
7.
Tangelder, Marco J.D., Cun Long, Jan Emmerechts, et al.. (2012). Antidote strategies to reverse anticoagulation with TB‐402, a long‐acting partial inhibitor of factor VIII. Journal of Thrombosis and Haemostasis. 10(7). 1371–1378. 5 indexed citations
8.
Peerlinck, K. & Marc Jacquemin. (2010). Mild haemophilia: a disease with many faces and many unexpected pitfalls. Haemophilia. 16(s5). 100–106. 36 indexed citations
9.
Witters, Peter, Kathleen Freson, Chris Verslype, et al.. (2008). Review article: blood platelet number and function in chronic liver disease and cirrhosis. Alimentary Pharmacology & Therapeutics. 27(11). 1017–1029. 130 indexed citations
10.
Berntorp, Erik, Jan Astermark, V. Blanchette, et al.. (2006). Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia. 12(s6). 1–7. 82 indexed citations
11.
Peerlinck, K. & Cédric Hermans. (2006). Epidemiology of inhibitor formation with recombinant factor VIII replacement therapy. Haemophilia. 12(6). 579–590. 25 indexed citations
12.
Peerlinck, K. & Marc Jacquemin. (2006). Characteristics of inhibitors in mild/moderate haemophilia A. Haemophilia. 12(s6). 43–47. 9 indexed citations
13.
Cuypere, Eveline, K. Peerlinck, Rik Verhaeghe, et al.. (2002). A VITAMIN K ANTAGONIST RAPIDLY REVERSES A BLUE TOE SYNDROME IN A PATIENT WITH LUPUS ANTICOAGULANT AND ANTIPROTHROMBIN ANTIBODIES. Acta Clinica Belgica. 57(2). 74–78. 2 indexed citations
14.
Kulkarni, Roshni, Louis M. Aledort, Erik Berntorp, et al.. (2002). Therapeutic choices for patients with hemophilia and high‐titer inhibitors. American Journal of Hematology. 69(2). 155–156. 1 indexed citations
15.
Kulkarni, Roshni, Erik Berntorp, Deborah Brown, et al.. (2001). Therapeutic choices for patients with hemophilia and high‐titer inhibitors. American Journal of Hematology. 67(4). 240–246. 46 indexed citations
16.
Peerlinck, K., Frits R. Rosendaal, & Jos Vermylen. (1993). Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitate. Blood. 81(12). 3332–3335. 39 indexed citations
17.
Peerlinck, K., FR Rosendaal, & Jos Vermylen. (1993). Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitate. Blood. 81(12). 3332–3335. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Pihusch Breakdown of academic impact, for papers by Omri Cohen Breakdown of academic impact, for papers by Rachel S. Bercovitz Breakdown of academic impact, for papers by F García‐Bragado Breakdown of academic impact, for papers by Francesca Sartorello Breakdown of academic impact, for papers by Joseph E. Palascak Breakdown of academic impact, for papers by Francesca Marangoni Breakdown of academic impact, for papers by Irwin Walker Breakdown of academic impact, for papers by Robert G. Lerner Breakdown of academic impact, for papers by Marta Magaz
Rankless by CCL
2026